articleGutAug 3, 2017Closed access

Suppressed hepatic bile acid signalling despite elevated production of primary and secondary bile acids in NAFLD

Tongji University · University at Buffalo, State University of New York

PubMed
Indexed incrossrefpubmed

Abstract

Objective

Bile acids are regulators of lipid and glucose metabolism, and modulate inflammation in the liver and other tissues. Primary bile acids such as cholic acid and chenodeoxycholic acid (CDCA) are produced in the liver, and converted into secondary bile acids such as deoxycholic acid (DCA) and lithocholic acid by gut microbiota. Here we investigated the possible roles of bile acids in non-alcoholic fatty liver disease (NAFLD) pathogenesis and the impact of the gut microbiome on bile acid signalling in NAFLD.

Design

Serum bile acid levels and fibroblast growth factor 19 (FGF19), liver gene expression profiles and gut microbiome compositions were determined in patients with NAFLD, high-fat diet-fed rats and their controls.

Citation impact

724
total citations
FWCI
23.98
Percentile
100%
References
52
Citations per year

Authors

12

Topics & keywords

Keywords
  • FGF19
  • Farnesoid X receptor
  • Deoxycholic acid
  • Bile acid
  • Internal medicine
  • Chenodeoxycholic acid
  • Cholic acid
  • CYP8B1
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding